Retraction notice to "Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors" [Heliyon 9 (2023) e13460]
- PMID: 40201495
- PMCID: PMC11948511
- DOI: 10.1016/j.heliyon.2025.e43143
Retraction notice to "Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors" [Heliyon 9 (2023) e13460]
Abstract
[This retracts the article DOI: 10.1016/j.heliyon.2023.e13460.].
© 2025 Published by Elsevier Ltd.
Retraction of
-
Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors.Heliyon. 2023 Feb 8;9(2):e13460. doi: 10.1016/j.heliyon.2023.e13460. eCollection 2023 Feb. Heliyon. 2023. Retraction in: Heliyon. 2025 Mar 12;11(6):e43143. doi: 10.1016/j.heliyon.2025.e43143. PMID: 36846693 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources